Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
EZCORP Inc. (NASDAQ: EZPW) shares soared 20.32 percent to close at $11.25 a share Wednesday. The stock traded between $10.71 and $11.88 on volume 4.56 million shares traded. The company reported revenues were $269.4 million for the first quarter of fiscal 2014, which topped analysts’ expectations of $257.5 million. Shares of EZCORP have fallen approximately 50.0 percent in the past year.
Get more information on EZCORP free access to the in-depth equity report at: www.FiveStarEquities.com/EZPW
Hanesbrands Inc. (NYSE: HBI) shares gained 1.40 percent to close at $65.07 a share Wednesday. The stock traded between $63.60 and $65.48 on volume of 1.68 million shares traded. The company has raised its quarterly dividend by 50.0 percent to $0.30 per share, which is to be paid on March 11, 2014, to stockholders of record at the close of business Feb. 18, 2014. Shares of Hanesbrands have gained approximately 70.0 percent in the past year.
Get more information on Hanesbrands and free access to the in-depth equity report at: www.FiveStarEquities.com/HBI
Kulicke and Soffa Industries Inc. (NASDAQ: KLIC) shares declined 1.66 percent to close at $11.83 a share Wednesday. The stock traded between $11.80 and $11.99 on volume 1.21 million shares traded. The company reported net revenue of $79.1 million for the first quarter of fiscal 2011, an increase of 30.0 percent when compared to a year ago. Shares of Kulicke and Soffa have fallen approximately 10.0 percent year-to-date.
Get more information on Kulicke and Soffa and free access to the in-depth equity report at: www.FiveStarEquities.com/KLIC
Novartis AG (NYSE: NVS) shares declined 0.36 percent to close at $79.27 a share Wednesday. The stock traded between $78.84 and $79.62 on volume 4.03 million shares traded. The company reported full-year net profit of $9.175 billion attributable to shareholders, compared to $9.27 billion a year ago. Shares of Novartis have gained approximately 18.0 percent in the past year.
Get more information on Novartis and free access to the in-depth equity report at: www.FiveStarEquities.com/NVS
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Contact: Five Star Equities [email protected]